RBC Capital Maintains Outperform on Exelixis, Raises Price Target to $34
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Gregory Renza has maintained an 'Outperform' rating on Exelixis (NASDAQ:EXEL) and raised the price target from $30 to $34.
October 16, 2024 | 12:27 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital has reaffirmed its 'Outperform' rating for Exelixis and increased the price target from $30 to $34, indicating positive expectations for the stock.
The increase in price target from $30 to $34 by RBC Capital suggests a positive outlook for Exelixis, likely leading to a short-term increase in stock price. The 'Outperform' rating indicates confidence in the company's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100